O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 10.75 GBX Market Closed
Market Cap: £55.7m

Wall Street
Price Targets

OBI Price Targets Summary
Ondine Biomedical Inc

There are no price targets for OBI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ondine Biomedical Inc Competitors:
Price Targets
9688
Zai Lab Ltd
56% Upside

Revenue
Forecast

-7% / Year
Past Growth
161% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
-7% / Year
Past Growth
161% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

For the last 3 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 161%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OBI's stock price target?
Not Available

OBI doesn't have any price targets made by Wall Street professionals.

What is Ondine Biomedical Inc's Revenue forecast?
Projected CAGR
161%

For the last 3 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 161%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett